Overview Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR Status: Completed Trial end date: 2020-12-03 Target enrollment: Participant gender: Summary A study to evaluate the efficacy of K-877 extended release (ER) once daily (QD) compared to K-877 immediate release (IR) twice daily (BID). Phase: Phase 2 Details Lead Sponsor: Kowa Research Institute, Inc.